Imagine your body is hosting a wild party, and some uninvited guests—it turns out, they're cancer cells—are causing havoc. What if you could spot these troublemakers before they get too rowdy? That's where lung cancer screening campaigns come in, and they're throwing quite the shindig in the world...
Meet CDK4/6 - a pair of molecular enforcers that tell your cells when it's time to divide. In healthy tissue, they're obedient middle managers, only green-lighting cell division when they get the right signals. But in cancer, they've gone full rogue employee: ignoring every memo from headquarters,...
Cancer vaccines have been the "next big thing" for about three decades. Every few years, the hype cycle spins up, a few high-profile trials disappoint, and the field quietly goes back to the lab. But something changed during COVID-19. The mRNA platform that Moderna and BioNTech used to develop...
Your body's immune system is already pretty good at spotting troublemakers. But cancer cells? They're the con artists of biology - wearing disguises, forging IDs, and generally making themselves very hard to catch. Traditional chemotherapy's solution has been to carpet-bomb the whole neighborhood...
Most people know CRISPR as the gene-editing tool that lets scientists cut DNA with surgical precision. What fewer people realize is that the same molecular machinery can be repurposed into an extraordinarily sensitive diagnostic platform. Instead of editing genes, CRISPR-based diagnostics detect...
In 1924, Otto Warburg noticed something strange: cancer cells consume enormous amounts of glucose and ferment it into lactate even when plenty of oxygen is available for normal respiration. This was weird. Aerobic glycolysis is wildly inefficient - you get 2 ATP per glucose molecule instead of the...
CAR-T cell therapy is one of the most impressive things humans have ever built. You take a patient's own T cells, genetically engineer them to recognize cancer, expand them into an army, and infuse them back in. For certain blood cancers, this is borderline miraculous - complete response rates that...
For years, oncologists operated under a tidy assumption: HER2-positive breast cancer and hormone receptor-positive breast cancer were essentially separate problems requiring separate playbooks. Target HER2 with trastuzumab and pertuzumab, treat HR+ disease with endocrine therapy and CDK4/6...
UCSF Research Team Discovers New Villain Hiding in Pancreatic Tumors After Knocking Out Fibroblast's Primary Communication Channel
If CD19-targeted CAR T cells had an Instagram, their bio would read: "First FDA-approved gene therapy 💉 | Pediatric cancer fighter since 2017 | 90% remission rate energy | Currently beefing with solid tumors 😤 | DMs open for B-ALL referrals only." And honestly? That profile would be verified.
Somewhere deep inside your body, you were born with a loaded weapon pointed at cancer - and at your own brain. That's the unsettling takeaway from a new study published in Nature that reads like a medical thriller worthy of its own Netflix adaptation.
Breast cancer mortality in the United States has a reputation problem. On paper, it looks like a success story - deaths dropped by 26% between 2000 and 2019, sliding from 33.6 to 24.8 per 100,000 women. Headlines love that number. Politicians quote it. And if you're a white woman living in a...
Imagine you've just had surgery to remove a lung tumor. The surgeon gives you a thumbs up, the pathology report looks clean, and everyone's cautiously optimistic. But here's the uncomfortable truth that keeps oncologists up at night: somewhere between 30% and 55% of patients with early-stage...
Cancer research loves a good paradox, and here's one that should make you suspicious of every "immunotherapy breakthrough" headline you've read this year: we've spent decades trying to unleash the immune system against tumors, yet almost nobody thought to ask whether the immune system's own...
BULLETIN - University of Virginia, 2026: A research team has just announced the development of the first drug ever designed to target a protein called advillin - and it shrank brain tumors in mice without apparent side effects. The compound crosses the blood-brain barrier. It could potentially be...
KARLSRUHE, GERMANY - A team of researchers has reportedly convinced silicon-based nanoparticles to cosplay as enzymes, perform chemistry in water without any metals, and then - in a move nobody asked for but everyone needed - sneak into brain and skin cancer cells to activate a cancer-killing drug....
If tumors ever handed out report cards, most cancer biologists would still be getting an Incomplete in "How Cells Actually Spread." We've spent decades studying individual cancer cells sneaking off on their own little field trips through the body, only to discover that the real troublemakers are...
Watch closely. In one hand, we have imatinib—the drug that transformed chronic myeloid leukemia from a death sentence into a manageable condition back in 2001. Revolutionary stuff. In the other hand, we have the newer second-generation TKIs that promised even better results. And now, for the...
Chess grandmasters and oncologists have more in common than either group would probably admit. Both spend years memorizing openings, studying their opponent's every move, and agonizing over decisions where one wrong call can change everything. The difference? Chess engines surpassed human...
FIELD DISPATCH - SUBCUTANEOUS FRONT, SECTOR 7-BRAVO